Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases
Krumme D, Wenzel H, Tschesche H (1998)
FEBS LETTERS 436(2): 209-212.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Krumme, D;
Wenzel, HerbertUniBi;
Tschesche, HaraldUniBi
Einrichtung
Abstract / Bemerkung
Novel peptides containing the sequence -Pro-Leu-Ama(NHOH)- were synthesized and characterized by spectroscopic techniques. Their inhibitory properties towards the activated form of native human gelatinase B (MMP-9) and the catalytic domain of neutrophil collagenase (cdMMP-8) were determined. The most effective inhibitor synthesized exhibits K-i values of 2 x 10(-6) Il I (cdMMP-8) and 5 x 10(-9) RI (MMP-9) thus attaining interesting discrimination between the tested metalloproteinases. A most important feature of this type of inhibitor is its peptide nature making the compounds similar to natural substrates. In spite of the peptide character of the inhibitors synthesized, the P-1-P-1'-peptide bond shows a high resistance to cleavage by the proteinases. (C) 1998 Federation of European Biochemical Societies.
Stichworte
aminomalonic acid;
peptide inhibitor;
matrix metalloproteinase;
inhibition;
hydroxamate
Erscheinungsjahr
1998
Zeitschriftentitel
FEBS LETTERS
Band
436
Ausgabe
2
Seite(n)
209-212
ISSN
0014-5793
Page URI
https://pub.uni-bielefeld.de/record/1624672
Zitieren
Krumme D, Wenzel H, Tschesche H. Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases. FEBS LETTERS. 1998;436(2):209-212.
Krumme, D., Wenzel, H., & Tschesche, H. (1998). Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases. FEBS LETTERS, 436(2), 209-212. https://doi.org/10.1016/S0014-5793(98)01128-4
Krumme, D, Wenzel, Herbert, and Tschesche, Harald. 1998. “Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases”. FEBS LETTERS 436 (2): 209-212.
Krumme, D., Wenzel, H., and Tschesche, H. (1998). Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases. FEBS LETTERS 436, 209-212.
Krumme, D., Wenzel, H., & Tschesche, H., 1998. Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases. FEBS LETTERS, 436(2), p 209-212.
D. Krumme, H. Wenzel, and H. Tschesche, “Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases”, FEBS LETTERS, vol. 436, 1998, pp. 209-212.
Krumme, D., Wenzel, H., Tschesche, H.: Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases. FEBS LETTERS. 436, 209-212 (1998).
Krumme, D, Wenzel, Herbert, and Tschesche, Harald. “Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases”. FEBS LETTERS 436.2 (1998): 209-212.
Daten bereitgestellt von European Bioinformatics Institute (EBI)
11 Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
Novel biodegradable, biomimetic and functionalised polymer scaffolds to prevent expansion of post-infarct left ventricular remodelling.
Cristallini C, Gagliardi M, Barbani N, Giannessi D, Guerra GD., J Mater Sci Mater Med 23(1), 2012
PMID: 22143909
Cristallini C, Gagliardi M, Barbani N, Giannessi D, Guerra GD., J Mater Sci Mater Med 23(1), 2012
PMID: 22143909
Inhibitors of gelatinase B/matrix metalloproteinase-9 activity comparison of a peptidomimetic and polyhistidine with single-chain derivatives of a neutralizing monoclonal antibody.
Hu J, Van den Steen PE, Houde M, Ilenchuk TT, Opdenakker G., Biochem Pharmacol 67(5), 2004
PMID: 15104254
Hu J, Van den Steen PE, Houde M, Ilenchuk TT, Opdenakker G., Biochem Pharmacol 67(5), 2004
PMID: 15104254
Rational design of tropoelastin peptide-based inhibitors of metalloproteinases.
Jensen SA, Andersen P, Vrhovski B, Weiss AS., Arch Biochem Biophys 409(2), 2003
PMID: 12504900
Jensen SA, Andersen P, Vrhovski B, Weiss AS., Arch Biochem Biophys 409(2), 2003
PMID: 12504900
Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.
Krumme D, Tschesche H., Bioorg Med Chem Lett 12(6), 2002
PMID: 11958997
Krumme D, Tschesche H., Bioorg Med Chem Lett 12(6), 2002
PMID: 11958997
General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.
Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P., Bioorg Med Chem Lett 11(3), 2001
PMID: 11212095
Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P., Bioorg Med Chem Lett 11(3), 2001
PMID: 11212095
Protease inhibitors: Synthesis of L-alanine hydroxamate sulfonylated derivatives as inhibitors of clostridium histolyticum collagenase.
Supuran CT, Briganti F, Mincione G, Scozzafava A., J Enzyme Inhib 15(2), 2000
PMID: 10938538
Supuran CT, Briganti F, Mincione G, Scozzafava A., J Enzyme Inhib 15(2), 2000
PMID: 10938538
Protease inhibitors. Part 7. Inhibition of Clostridium histolyticum collagenase with sulfonylated derivatives of L-valine hydroxamate.
Supuran CT, Scozzafava A., Eur J Pharm Sci 10(1), 2000
PMID: 10699384
Supuran CT, Scozzafava A., Eur J Pharm Sci 10(1), 2000
PMID: 10699384
Protease inhibitors. Part 8: synthesis of potent Clostridium histolyticum collagenase inhibitors incorporating sulfonylated L-alanine hydroxamate moieties.
Scozzafava A, Supuran CT., Bioorg Med Chem 8(3), 2000
PMID: 10732980
Scozzafava A, Supuran CT., Bioorg Med Chem 8(3), 2000
PMID: 10732980
Protease inhibitors - part 5. Alkyl/arylsulfonyl- and arylsulfonylureido-/arylureido- glycine hydroxamate inhibitors of Clostridium histolyticum collagenase.
Scozzafava A, Supuran CT., Eur J Med Chem 35(3), 2000
PMID: 10785556
Scozzafava A, Supuran CT., Eur J Med Chem 35(3), 2000
PMID: 10785556
Protease inhibitors. Part 12. Synthesis of potent matrix metalloproteinase and bacterial collagenase inhibitors incorporating sulfonylated N-4-nitrobenzyl-beta-alanine hydroxamate moieties.
Scozzafava A, Ilies MA, Manole G, Supuran CT., Eur J Pharm Sci 11(1), 2000
PMID: 10913755
Scozzafava A, Ilies MA, Manole G, Supuran CT., Eur J Pharm Sci 11(1), 2000
PMID: 10913755
Determination of matrix metalloproteinase activity using biotinylated gelatin.
Ratnikov B, Deryugina E, Leng J, Marchenko G, Dembrow D, Strongin A., Anal Biochem 286(1), 2000
PMID: 11038285
Ratnikov B, Deryugina E, Leng J, Marchenko G, Dembrow D, Strongin A., Anal Biochem 286(1), 2000
PMID: 11038285
16 References
Daten bereitgestellt von Europe PubMed Central.
Matrix metalloproteinases: a review.
Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA., Crit. Rev. Oral Biol. Med. 4(2), 1993
PMID: 8435466
Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA., Crit. Rev. Oral Biol. Med. 4(2), 1993
PMID: 8435466
Collagenase inhibitors: their design and potential therapeutic use.
Johnson WH, Roberts NA, Borkakoti N., J. Enzym. Inhib. 2(1), 1987
PMID: 2854154
Johnson WH, Roberts NA, Borkakoti N., J. Enzym. Inhib. 2(1), 1987
PMID: 2854154
Synthetic inhibitors of bacterial and mammalian interstitial collagenases.
Schwartz MA, Van Wart HE., Prog Med Chem 29(), 1992
PMID: 1475372
Schwartz MA, Van Wart HE., Prog Med Chem 29(), 1992
PMID: 1475372
The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity.
Bode W, Reinemer P, Huber R, Kleine T, Schnierer S, Tschesche H., EMBO J. 13(6), 1994
PMID: 8137810
Bode W, Reinemer P, Huber R, Kleine T, Schnierer S, Tschesche H., EMBO J. 13(6), 1994
PMID: 8137810
Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor.
Grams F, Crimmin M, Hinnes L, Huxley P, Pieper M, Tschesche H, Bode W., Biochemistry 34(43), 1995
PMID: 7577999
Grams F, Crimmin M, Hinnes L, Huxley P, Pieper M, Tschesche H, Bode W., Biochemistry 34(43), 1995
PMID: 7577999
Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor.
Borkakoti N, Winkler FK, Williams DH, D'Arcy A, Broadhurst MJ, Brown PA, Johnson WH, Murray EJ., Nat. Struct. Biol. 1(2), 1994
PMID: 7656013
Borkakoti N, Winkler FK, Williams DH, D'Arcy A, Broadhurst MJ, Brown PA, Johnson WH, Murray EJ., Nat. Struct. Biol. 1(2), 1994
PMID: 7656013
1.56 A structure of mature truncated human fibroblast collagenase.
Spurlino JC, Smallwood AM, Carlton DD, Banks TM, Vavra KJ, Johnson JS, Cook ER, Falvo J, Wahl RC, Pulvino TA., Proteins 19(2), 1994
PMID: 8090713
Spurlino JC, Smallwood AM, Carlton DD, Banks TM, Vavra KJ, Johnson JS, Cook ER, Falvo J, Wahl RC, Pulvino TA., Proteins 19(2), 1994
PMID: 8090713
On the size of the active site in proteases. I. Papain.
Schechter I, Berger A., Biochem. Biophys. Res. Commun. 27(2), 1967
PMID: 6035483
Schechter I, Berger A., Biochem. Biophys. Res. Commun. 27(2), 1967
PMID: 6035483
AUTHOR UNKNOWN, 0
Latent collagenase and gelatinase from human neutrophils and their activation.
Tschesche H, Knauper V, Kramer S, Michaelis J, Oberhoff R, Reinke H., Matrix Suppl 1(), 1992
PMID: 1480034
Tschesche H, Knauper V, Kramer S, Michaelis J, Oberhoff R, Reinke H., Matrix Suppl 1(), 1992
PMID: 1480034
The recombinant catalytic domain of human neutrophil collagenase lacks type I collagen substrate specificity.
Schnierer S, Kleine T, Gote T, Hillemann A, Knauper V, Tschesche H., Biochem. Biophys. Res. Commun. 191(2), 1993
PMID: 8460992
Schnierer S, Kleine T, Gote T, Hillemann A, Knauper V, Tschesche H., Biochem. Biophys. Res. Commun. 191(2), 1993
PMID: 8460992
A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases.
Knight CG, Willenbrock F, Murphy G., FEBS Lett. 296(3), 1992
PMID: 1537400
Knight CG, Willenbrock F, Murphy G., FEBS Lett. 296(3), 1992
PMID: 1537400
Synthetic substrates of vertebrate collagenase.
Weingarten H, Martin R, Feder J., Biochemistry 24(23), 1985
PMID: 3002449
Weingarten H, Martin R, Feder J., Biochemistry 24(23), 1985
PMID: 3002449
Fields, J. Biol. Chem. 262(), 1973
Sequence specificities of human fibroblast and neutrophil collagenases.
Netzel-Arnett S, Fields GB, Birkedal-Hansen H, Van Wart HE, Fields G., J. Biol. Chem. 266(11), 1991
PMID: 1849891
Netzel-Arnett S, Fields GB, Birkedal-Hansen H, Van Wart HE, Fields G., J. Biol. Chem. 266(11), 1991
PMID: 1849891
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 9781680
PubMed | Europe PMC
Suchen in
Google Scholar